View of Effective Reduction of Inflammatory and Coagulation Factors using Sitagliptin in Type 2 Diabetes | Iranian Red Crescent Medical Journal

← Effective Reduction of Inflammatory and Coagulation Factors using Sitagliptin in Type 2 Diabetes